A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression

NCT00624858 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: naltrexone SR 32 mg/ bupropion SR 360 mg daily

Sponsor

Orexigen Therapeutics, Inc